MICHAEL JOHNSON to Economics, Pharmaceutical
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Economics, Pharmaceutical.
Connection Strength
0.814
-
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III. Value Health. 2009 Nov-Dec; 12(8):1062-73.
Score: 0.362
-
Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II. Value Health. 2009 Nov-Dec; 12(8):1053-61.
Score: 0.361
-
Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Value Health. 2009 Nov-Dec; 12(8):1044-52.
Score: 0.091